PMID- 23825670 OWN - NLM STAT- MEDLINE DCOM- 20140207 LR - 20221207 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 6 DP - 2013 TI - Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population. PG - e67585 LID - 10.1371/journal.pone.0067585 [doi] LID - e67585 AB - BACKGROUND: Age-specific prostate specific antigen (PSA) cutoffs for prostate biopsy have been widely used in the USA and European countries. However, the application of age-specific PSA remains poorly understood in China. METHODS: Between 2003 and 2012, 1,848 men over the age of 40, underwent prostate biopsy for prostate cancer (PCa) at Huashan Hospital, Shanghai, China. Clinical information and blood samples were collected prior to biopsy for each patient. Men were divided into three age groups (80) for analyses. Digital rectal examination (DRE), transrectal ultrasound (prostate volume and nodule), total PSA (tPSA), and free PSA (fPSA) were also included in the analyses. Logistic regression was used to build the multi-variate model. RESULTS: Serum tPSA levels were age-dependent (P = 0.008), while %fPSA (P = 0.051) and PSAD (P = 0.284) were age-independent. At a specificity of 80%, the sensitivities for predicting PCa were 83%, 71% and 68% with tPSA cutoff values of 19.0 ng/mL (age/=81). Also, sensitivities at the same tPSA levels were able to reach relatively high levels (70%-88%) for predicting high-grade PCa. Area (AUC) under the receive operating curves (ROCs) of tPSA, %fPSA, PSAD and multi-variate model were different in age groups. When predicting PCa, the AUC of tPSA, %fPSA, PSAD and multi-variate model were 0.90, 0.57, 0.93 and 0.87 respectively in men 80 yr. When predicting Gleason Score >/=7 or 8 PCa, there were no significant differences between AUCs of each variable. CONCLUSION: Age-specific PSA cutoff values for prostate biopsy should be considered in the Chinese population. Indications for prostate biopsies (tPSA, %fPSA and PSAD) should be considered based on age in the Chinese population. FAU - Na, Rong AU - Na R AD - Department of Urology, Huashan Hospital, Fudan University, Shanghai, China. FAU - Wu, Yishuo AU - Wu Y FAU - Xu, Jianfeng AU - Xu J FAU - Jiang, Haowen AU - Jiang H FAU - Ding, Qiang AU - Ding Q LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130625 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - EC 3.4.21.77 (Prostate-Specific Antigen) SB - IM MH - Age Factors MH - Aged MH - Aged, 80 and over MH - *Asian People MH - Biopsy/*standards MH - *Decision Making MH - Humans MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Prostate/pathology MH - Prostate-Specific Antigen/*blood MH - Prostatic Neoplasms/blood/pathology MH - ROC Curve MH - Reference Standards PMC - PMC3692456 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/07/05 06:00 MHDA- 2014/02/08 06:00 PMCR- 2013/06/25 CRDT- 2013/07/05 06:00 PHST- 2013/02/23 00:00 [received] PHST- 2013/05/19 00:00 [accepted] PHST- 2013/07/05 06:00 [entrez] PHST- 2013/07/05 06:00 [pubmed] PHST- 2014/02/08 06:00 [medline] PHST- 2013/06/25 00:00 [pmc-release] AID - PONE-D-13-08243 [pii] AID - 10.1371/journal.pone.0067585 [doi] PST - epublish SO - PLoS One. 2013 Jun 25;8(6):e67585. doi: 10.1371/journal.pone.0067585. Print 2013.